# Filing Detail

Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0001829126-25-005721
Filing Date
2025-08-04
Accepted
2025-08-01 21:23:07
Documents
8

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | filename1.htm | DRS/A | 5125620
2 | GRAPHIC | img_001a.jpg | GRAPHIC | 18921
3 | GRAPHIC | img_001.jpg | GRAPHIC | 53692
4 | GRAPHIC | img_002a.jpg | GRAPHIC | 7930
5 | GRAPHIC | img_003.jpg | GRAPHIC | 12985
6 | GRAPHIC | img_004.jpg | GRAPHIC | 21918
7 | GRAPHIC | img_005.jpg | GRAPHIC | 63700
8 | GRAPHIC | img_006.jpg | GRAPHIC | 33572
| Complete submission text file | 0001829126-25-005721.txt |  | 5417705

Mailing Address 207 S. SANTA ANITA STREET, SUITE P-15 SAN GABRIEL CA 91776
Business Address 207 S. SANTA ANITA STREET, SUITE P-15 SAN GABRIEL CA 91776 (626) 400-6603
Vesicor Therapeutics, Inc. (Filer) CIK: 0001993074 (see all company filings)

EIN.: 262470586 | State of Incorp.: CA | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-08098-01 | Film No.: 251177792

Mailing Address 4125 BLACKHAWK PLAZA CIRCLE SUITE 166 DANVILLE CA 94506
Business Address 4125 BLACKHAWK PLAZA CIRCLE SUITE 166 DANVILLE CA 94506 203-520-7122
Black Hawk Acquisition Corp (Filer) CIK: 0002000775 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1130
Type: DRS/A | Act: 33 | File No.: 377-08098 | Film No.: 251177791
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)